Molecular Diagnostics of Adrenal Tumors
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Genetic Diagnosis".
Deadline for manuscript submissions: 10 October 2025 | Viewed by 48
Special Issue Editor
2. EndoLab Laboratory, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland
Interests: adrenal tumors; metabolomics; proteomics; immunochemistry; clinical biochemistry; endocrinology; genetics
Special Issue Information
Dear Colleagues,
Adrenal tumors are often diagnosed incidentally during imaging examinations. Adrenal tumors can be benign, malignant, hormonal or non-hormonal. They can occur sporadically or as part of genetic syndromes. Molecular testing is now an important part of clinical diagnostics.
Significant progress in the field of molecular research of adrenal tumors has been made in the molecular characterization of tumors secreting catecholamines (pheochromocytomas and paragangliomas—PPGLs) and tumors with hypersecretion of adrenal cortex hormones, such as Cushing's syndrome, primary aldosteronism, and adrenocortical cancer. The development of modern molecular techniques, including NGS, transcriptomics, etc., has facilitated studies of/the search for new genetic variants. Molecular studies complement clinical diagnostics and can be particularly useful for assessing and planning personalized (tailored) treatment/diagnostics, and they are of great importance for genetic counseling.
The Special Issue requests original or review manuscripts on molecular studies in the field of adrenal tumors (particularly in clinical terms).
Dr. Piotr Glinicki
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adrenal tumors
- pheochromocytoma
- paraganglioma
- Cushing syndrome
- primary aldosteronism
- adrenocortical cancer
- molecular testing
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
